Kris V Kowdley

发表

Review of direct-acting antiviral agents for the treatment of chronic hepatitis C

Nihar Shah, K. Kowdley, Tracey Pierce, 2013, Expert opinion on investigational drugs.

Adiponectin--tipping the scales from NAFLD to NASH?

Kris V Kowdley, Daniel S Pratt, 2005, Gastroenterology.

Sofosbuvir for previously untreated chronic hepatitis C infection.

John McNally, Michael Schultz, A. Mangia, 2013, The New England journal of medicine.

Post-treatment resistance analysis of hepatitis C virus from phase II and III clinical trials of ledipasvir/sofosbuvir.

H. Mo, K. Kowdley, B. Doehle, 2017, Journal of Hepatology.

Correlation of proton transverse relaxation rates (R2) with iron concentrations in postmortem brain tissue from alzheimer's disease patients

T. Montine, J. Connor, M. House, 2007, Magnetic resonance in medicine.

ABT-450/r-ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosis.

Thomas Berg, Stefan Zeuzem, Xavier Forns, 2014, The New England journal of medicine.

Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis.

Robert Herring, Vinod Rustgi, E. Schiff, 2014, The New England journal of medicine.

The effect of periodic monitoring and feedback on screening colonoscopy withdrawal times, polyp detection rates, and patient satisfaction scores.

Michael Gluck, R. Kozarek, K. Kowdley, 2008, Gastrointestinal endoscopy.

Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international study

Andrew K Burroughs, Pietro Invernizzi, Frederik Nevens, 2015, Gut.

Treatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin.

Eoin Coakley, Junyuan Xiong, Jordan J Feld, 2014, The New England journal of medicine.